For Immediate Release 31 July Devro plc INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE Strong sales growth follows capacity expansion investments Devro plc ( Devro or the group ), one of the world s leading manufacturers of collagen products for the food industry, is pleased to announce its interim results for the six months. Financial highlights (continuing operations) Revenues of 115.4m (: 107.1m) +7.7% Operating profit of 20.7m (: 19.5m), despite higher input costs +6.5% Profit before tax excluding net finance expense/income on pension of 20.2m (: 19.1m) +5.7% Basic earnings per share excluding net finance expense/income on pension of 9.9p (: +7.6% 9.2p) Interim dividend of 2.65p per share (: 2.5p) +6.0% Net debt increased, as expected following the investment programme, to 31.4m (: 24.0m) Corporate highlights Continued strong sales growth in Japan, South East Asia, Eastern Europe and Latin America Select sales increase in Europe and Japan and now account for 8.1% of total group sales Recent capital expenditure delivering benefits Significant ongoing capital programme to deliver further capacity increase in 2013 New board and senior management appointments Other statutory financial highlights (continuing operations) Profit before tax unchanged at 19.6m (: 19.6m) Basic earnings per share unchanged at 9.5p (: 9.5p) Steve Hannam, Chairman of Devro, commented Sales have increased across a wide range of markets and the good momentum from the second half of has continued into. The outlook for the remainder of the year is for continued volume growth particularly of sales of differentiated products such as Select, supported by further manufacturing improvements arising from our capital programme. We remain on track to meet the Board s expectations for the full year. For further information contact: Peter Page Chief Executive 0207 466 5000 (31 July ) Simon Webb Finance Director 0207 466 5000 Diane Stewart/ Charles Ryland / Carrie Clement Buchanan 0207 466 5000 There will be a presentation today at 9.30am for investment analysts. This will be held at the offices of Buchanan, 107 Cheapside, London, EC2V 6DN. A live audio feed will be available to those unable to attend this meeting in person. To connect to the web cast facility, please go to the following link: http://mediaserve.buchanan.uk.com//devro310712/registration.asp approximately 10 minutes (9.20am) before the start of the briefing. The presentation will also be available on the company s website.
Chairman s statement and operating review Devro has made good progress in the six months to, with growth of 7.7% in sales revenue and 6.5% in operating profit from continuing operations, compared to the corresponding period in. Sales of our premium Select range, which is specifically designed to replicate the characteristics of high quality sheep gut in developed markets, continue to grow strongly in Japan and Europe, and we are now achieving our target for Select of 8% of total sales. Following the sale of Devro GmbH on 30 September, the figures in the statement refer to the continuing business, unless stated otherwise. Operating review Overall market The global market for collagen casings continues to expand due to economic growth and increased meat consumption in emerging markets. High sheep gut prices and limited availability also provide good opportunities in developed markets for substitution by collagen casing. Trading overview Sales revenue for the first half of rose to 115.4 million from 107.1 million, with operating profits up to 20.7m from 19.5m in. This 6.5% improvement in operating profits reflects volume growth of 3.0 million, higher average selling prices of 0.9 million due mainly to the growth of Select, changes in country mix of 0.5 million and manufacturing efficiencies of 1.5 million. This was partly offset by higher input costs of approximately 2.1 million which are expected to remain at current levels for the second half of the year. There was also an adverse currency movement impact of 0.6 million together with general inflationary increases of 2.0 million. Sales Compared to, edible collagen volumes and values were 9.1% and 11.0% higher respectively, as a result of the increased capacity and sales of higher value products. Europe Edible collagen volumes in continental Europe continue to increase, particularly in Eastern Europe, Scandinavia and Germany with sales of Select making a significant contribution to this increase. The Euro difficulties have had limited impact on the levels of demand and sales. UK and Ireland volumes, as expected, were down as a small number of product lines moved back to hog gut casing. Non edible collagen sales, which represent 5% of total revenue, were down due to a more competitive pricing environment in the non-edible casing market and a general weakness in demand which is expected to recover in the second half of the year. Americas Edible collagen volumes in the Americas increased considerably with solid growth in Latin American markets. Strong manufacturing performance compared to the prior year assisted in the improved availability of product to satisfy demand. Collagen gel sales remain close to their levels with good gains at several accounts compensating for one large customer having reverted to collagen casing in. Asia/Pacific Total volumes were up in Asia/Pacific with Japan showing significant growth reflecting the demand for Select. South East Asia and Korea also continue to grow. 2
Future developments The Board has approved a further 35 million of investments in to increase capacity and enhance productivity, of which 10.2 million has been invested in the first half. The recently installed lines in Scotland are now in full production and commissioning continues on the new line in the USA. Investment in additional capacity in the Czech Republic is proceeding as planned, with a small number of lines being temporarily decommissioned in sequence during the upgrade programme. This significant project will continue into 2013 and the full benefits will start to come through in late 2013. Foreign currency Devro operates worldwide and with multiple currencies. Major transactional exposures arise from sales in euros, US dollars and Japanese yen whereas manufacturing costs are in Australian dollars, Czech koruna, US dollars and sterling. Translational exposures arise from the conversion of the results of all our businesses into sterling. The net impact of exchange rate movements on operating profit in the six months to June was adverse by 0.6 million compared to the same period in.there was an overall translation loss of 1.2 million driven by the weakening of the Czech koruna against sterling partially offset by transactional gain of 0.6 million due to weak Czech koruna against euro and US dollar. Assuming exchange rates remain at the current levels, we would expect a similar effect in the second half of the year. The group had Euro trade receivables of 12 million at, of which 14% related to Spain, Portugal, Italy and Greece. Finance Finance income/expense Net interest expense for the period was 0.6 million (: 0.4 million). In addition there was net finance expense on pension assets and liabilities amounting to 0.6 million, which compares with net finance income of 0.5 million for the comparable period in, leading to a 1.1 million adverse impact on earnings which is non-cash in nature. The income was due primarily to the return on the pension assets being assumed to be greater than the discount on the liabilities, which has not materialised at that level. This has led to a lower assumed return on net assets in the future. Tax The group s tax charge for the period was 3.9 million which represents an effective tax rate of 19.7% (Full year : 20.5%). The group is benefiting from a low tax rate in the Czech Republic, including the impact of a capital investment incentive scheme. This is expected to continue until 2017. Earnings per share Continuing operations: Basic earnings per share excluding net finance (expense)/income 9.9p 9.2p Basic earnings per share 9.5p 9.5p Excluding movement on pension fund expense/income, earnings per share has increased by 7.6% to 9.9 pence from 9.2 pence, reflecting the increased profitability of the business partly offset by an increase in interest costs. Basic earnings per share has been shown excluding net finance income/expense on pension assets and liabilities in order to better reflect the underlying movement on trading results. 3
Net debt Net debt was, as expected, 31.4 million at compared to 22.7 million at 31 December, which reflects the cash outlay on fixed assets of 15.8 million. Pensions The group s retirement benefit obligations have increased from 46.2 million at 31 December to 51.5 million at. This primarily reflects a further fall in discount rates. Discussions with the trustees of the UK defined benefit pension scheme as part of the triennial valuation as at 31 March have now been concluded and it has been agreed to increase the cash contribution to fund the deficit from 1.1m to 1.5m per annum from 2013. A special one off contribution of 0.5 million into the US defined benefit scheme is also planned in the last quarter of in order to maintain the planned funding levels. Dividends The Board is pleased to announce an interim dividend of 2.65 pence (: 2.5 pence). The interim dividend will be paid on 5 October to shareholders on the register at 31 August. Board and Senior Management Appointments Jane Lodge joined the Board on 1 March and took over the role of Audit Committee Chair on 19 April replacing Stuart Paterson. The senior executive team has been expanded with the appointment of a Group HR Director and a Group Strategy and Marketing Director. Principal risks and uncertainties The group set out in its Annual Report and Financial Statements the principal risks and uncertainties that could impact its performance. These remain unchanged since the Annual Report was published. The group operates a structured risk management process, which identifies and evaluates risks and uncertainties and reviews mitigation activity. The main areas of potential risk and uncertainty are disruption to supply and increases in price of key raw materials, foreign exchange rate movements, customer credit risks, increased funding of pension schemes, the impact of changes in regulations affecting food production, food industry health concerns, increases in energy costs, loss of market share/profit margins due to increased competitive pressures and development of non-casing technologies. These risks, together with examples of mitigating activity, are set out in more detail on pages 14 and 15 of the Annual Report which is available on the Devro plc website: www.devro.com Outlook The outlook for the remainder of the year is for continued volume growth particularly of sales of differentiated products such as Select, supported by further manufacturing improvements arising from our capital programme. We remain on track to meet the Board s expectations for the full year. Steve Hannam Chairman Peter Page Chief Executive 31 July 4
Financial highlights six months Continuing operations Revenue 115.4m 107.1m Operating profit 20.7m 19.5m Profit before tax excluding net finance expense/income on pension 20.2m 19.1m Basic earnings per share excluding net finance expense/income on pension 9.9p 9.2p Interim dividend per share 2.65p 2.5p Net debt 31.4m 24.0m Discontinued operation Profit before tax - 0.1m 5
Interim consolidated income statement for the six months (unaudited) (unaudited) Continuing operations Revenue (note 5) 115,401 107,106 -- -- Operating profit 20,749 19,484 Finance income 26 86 Finance expense (577) (468) Net finance (expense)/income on pension assets and liabilities (613) 547 - - Profit before taxation 19,585 19,649 Taxation (note 7) (3,852) (4,028) - - Profit for the period from continuing operations 15,733 15,621 Discontinued operation (note 6) Profit for the period from discontinued operation - 66 - - Profit for the period 15,733 15,687 ===== ===== Earnings per share continuing operations (note 8) Basic 9.5p 9.5p Diluted 9.4p 9.4p 6
Interim consolidated statement of comprehensive income for the six months (unaudited) (unaudited) Profit for the period 15,733 15,687 - - Other comprehensive income for the period, net of tax Cash flow hedges: - net fair value gains 1,527 1,361 - reclassified and reported in operating profit (300) (1,113) - movement in deferred tax 60 (64) Group pension schemes: - actuarial loss recognised (7,271) (505) - movement in deferred tax 2,373 108 Net exchange adjustments (5,421) 7,456 - - Other comprehensive (expense)/income for the period, net of tax (9,032) 7,243 - - Total comprehensive income for the period 6,701 22,930 ===== ===== Total comprehensive income arises from: - continuing operations 6,701 22,778 - discontinued operation - 152 - - 6,701 22,930 ===== ===== 7
Interim consolidated balance sheet at (unaudited) 31 December (audited) (unaudited) Assets Non-current assets Intangible assets (note 10) 3,603 3,678 3,423 Property, plant and equipment (note 11) 178,191 180,215 170,369 Deferred tax assets 19,632 18,390 7,750 --- --- --- 201,426 202,283 181,542 --- --- --- Current assets Inventories 30,840 27,556 32,497 Current tax assets - 779 7 Trade and other receivables 35,816 34,820 32,646 Derivative financial instruments 1,544 572 1,173 Cash and cash equivalents 10,441 7,614 13,402 - - - 78,641 71,341 79,725 Assets of disposal group classified as held for sale (note 6) - - 4,934 - - - 78,641 71,341 84,659 --- --- --- Total assets 280,067 273,624 266,201 ====== ====== ====== Liabilities Current liabilities Bank overdrafts 4,931 2,213 4,321 Borrowings - - 33,102 Derivative financial instruments 755 1,615 376 Trade and other payables 25,734 33,256 28,700 Current tax liabilities 4,116 3,833 2,653 - - - 35,536 40,917 69,152 Liabilities of disposal group classified as held for sale (note 6) - - 3,313 - - - 35,536 40,917 72,465 - - - Non-current liabilities Borrowings 36,942 28,103 - Deferred tax liabilities 16,250 16,631 14,497 Retirement benefit obligations (note 13) 51,450 46,158 10,261 Other non-current liabilities 1,356 1,336 773 - - - 105,998 92,228 25,531 -- --- -- Total liabilities 141,534 133,145 97,996 ====== ====== ====== Net assets 138,533 140,479 168,205 ====== ====== ====== Equity Capital and reserves attributable to equity holders Ordinary shares 16,553 16,501 16,465 Share premium 7,968 7,642 7,430 Other reserves 75,819 79,917 92,905 Retained earnings 38,193 36,419 51,405 -- -- -- Total equity 138,533 140,479 168,205 ====== ====== ====== The above consolidated balance sheet should be read in conjunction with the accompanying notes. 8
Interim consolidated statement of changes in equity for the six months Ordinary shares Share premium Other reserves Retained earnings Total equity Six months Balance at 1 January 16,501 7,642 79,917 36,419 140,479 Comprehensive income Profit for the period - - - 15,733 15,733 Other comprehensive income Cash flow hedges, net of tax - - 1,287-1,287 Retirement benefit obligations, net of tax - - - (4,898) (4,898) Exchange adjustments - - (5,421) - (5,421) Total other comprehensive income - - (4,134) (4,898) (9,032) Total comprehensive income - - (4,134) 10,835 6,701 Transactions with owners Performance share plan charge - - 414-414 Performance share plan credit in respect of shares - - (378) - (378) vested Issue of ordinary shares 52 326 - - 378 Dividends paid - - - (9,061) (9,061) Total transactions with owners 52 326 36 (9,061) (8,647) Balance at (unaudited) 16,553 ===== Six months 7,968 ===== 75,819 ===== 38,193 ===== 138,533 ====== Balance at 1 January 16,361 6,773 85,607 44,259 153,000 Comprehensive income Profit for the period - - - 15,687 15,687 Other comprehensive income Cash flow hedges, net of tax - - 184-184 Retirement benefit obligations, net of tax - - - (397) (397) Exchange adjustments - - 7,456-7,456 Total other comprehensive income - - 7,640 (397) 7,243 Total comprehensive income - - 7,640 15,290 22,930 Transactions with owners Performance share plan charge - - 480-480 Performance share plan credit in respect of shares - - (822) - (822) vested Issue of ordinary shares 104 657 - - 761 Dividends paid - - - (8,144) (8,144) Total transactions with owners 104 657 (342) (8,144) (7,725) Balance at (unaudited) 16,465 ===== 7,430 ===== 92,905 ===== 51,405 ===== 168,205 ====== 9
Interim consolidated cash flow statement for the six months (unaudited) (unaudited) Cash flows from operating activities Continuing operations: - Cash generated from operations (note 15) 19,102 15,464 - Interest received 47 124 - Interest paid (545) (527) - Tax paid (1,875) (2,905) Discontinued operation (note 6) - (1,350) -- -- Net cash from operating activities 16,729 10,806 -- -- Cash flows from investing activities Continuing operations: - Purchase of property, plant and equipment (15,752) (14,812) - Proceeds from sale of property, plant and equipment 87 23 - Purchase of intangible assets (503) (843) Discontinued operation (note 6) - (4) -- -- Net cash used in investing activities (16,168) (15,636) -- -- Cash flows from financing activities Continuing operations: - Proceeds from the issue of ordinary shares 378 761 - Net borrowing under the loan facilities 8,995 17,783 - Dividends paid (9,061) (8,144) - Amounts advanced to disposal group - (915) Discontinued operation (note 6) - 915 -- -- Net cash from financing activities 312 10,400 -- -- Net increase in cash and cash equivalents 873 5,570 Cash and cash equivalents at beginning of period 5,401 2,995 Exchange (losses)/gains on cash and cash equivalents (764) 935 Cash and cash equivalents 10,441 13,821 Bank overdrafts (4,931) (4,321) Net cash and cash equivalents at end of period 5,510 9,500 Less: cash held by disposal group (note 6) - (419) -- -- Net cash and cash equivalents at end of period excluding disposal group 5,510 9,081 ===== ===== 10
Notes to the condensed interim consolidated financial statements for the six months (unaudited) 1 General information Devro is one of the world s leading providers of collagen products for the food industry. Collagen is one of the most common forms of protein, which is transformed into strong but flexible edible casings and other related products by highly sophisticated biochemical processing technologies. The company is a public limited company incorporated and domiciled in the UK. The address of its registered office is Moodiesburn, Chryston, Scotland, G69 0JE. The company is listed on the London Stock Exchange. These condensed interim consolidated financial statements were approved for issue on 31 July. These condensed interim consolidated financial statements do not comprise statutory accounts within the meaning of Section 434 of the Companies Act 2006. The consolidated interim financial statements are unaudited but have been reviewed by our auditors and their report is set out on pages 24 and 25. Statutory accounts for the year 31 December were approved by the Board of Directors on 12 March and delivered to the Registrar of Companies. The report of the auditors on those accounts was unqualified, did not contain an emphasis of matter paragraph and did not contain any statement under Section 498 of the Companies Act 2006. 2 Basis of preparation These condensed interim consolidated financial statements for the six months have been prepared in accordance with the Disclosure and Transparency Rules of the Financial Services Authority and with International Accounting Standard ( IAS ) 34, Interim financial reporting as adopted by the European Union. The condensed consolidated interim financial statements should be read in conjunction with the annual financial statements for the year 31 December which have been prepared in accordance with International Financial Reporting Standards ( IFRSs ) as adopted by the European Union. Critical estimates and judgments The preparation of financial statements in conformity with IFRSs requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on management s best assessments of amounts, events or actions, actual results ultimately may differ from those estimates. The key uncertainties that have a significant risk of causing material adjustment to the carrying amounts of assets and liabilities within the next six months are the measurement of retirement benefit obligations and taxation. Going concern basis Devro renegotiated its banking facilities in September and has new 5-year revolving facilities of 51.0 million. At, the group was operating comfortably within the covenants relating to these facilities. The directors have a reasonable expectation that the company and the group have adequate resources to continue in operation for the foreseeable future and therefore, the directors continue to adopt the going concern basis in preparing the consolidated interim financial statements. 11
3 Accounting policies The accounting policies adopted are consistent with those of the annual financial statements for the year 31 December, as described in those annual financial statements. New standards, amendments to standards or interpretations effective in The following new standards, amendments to standards or interpretations became mandatory for the first time during the financial year beginning 1 January. They either were not relevant for the group or had no material impact on the financial statements of the group: Effective date IAS 12 (amendments) Income taxes 1 January IAS 1 (amendments) Financial statement presentation 1 July regarding other comprehensive income New standards, amendments to standards or interpretations not applied At the date of approval of these financial statements, the following amendments to standards and interpretations were in issue but have not been applied in these financial statements: Effective date IFRS 9 Financial instruments 1 January 2015 IFRS 10 Consolidated financial statements 1 January 2013 IFRS 11 Joint arrangements 1 January 2013 IFRS 12 Disclosures of interests in other entities 1 January 2013 IFRS 13 Fair value measurement 1 January 2013 IAS 19 (revised ) - Employee benefits 1 January 2013 IAS 27 (revised ) - Separate financial statements 1 January 2013 IAS 28 (revised ) Associates and joint ventures 1 January 2013 It is expected that the group will adopt these standards, amendments to standards and interpretations on their effective dates. The most relevant for the group is the amendment to IAS 19 'Employee benefits.' This amendment is not expected to have a material change to net finance income/expense on pension assets and liabilities when applied, subject to volatility going forward. The directors do not anticipate that the adoption of the other amendments to standards and interpretations will have a material impact on the financial statements of the group. 12
4 Financial risk management The group s activities expose it to a variety of financial risks: market risk (including interest rate risk and foreign exchange risk), credit risk and liquidity risk. The condensed interim consolidated financial statements do not include all financial risk management information and disclosures required in annual financial statements, and should be read in conjunction with the group s annual financial statements for the year 31 December. Liquidity risk At, the group had in place unsecured floating rate loan facilities comprising committed elements with a total of 51.0 million (31 December : 51.0 million) and uncommitted working capital elements with a total of 11.9 million (31 December : 9.5 million). The committed elements are co-ordinated bilateral facilities which were renegotiated with four banks in September. The committed elements are due to expire on 30 September 2016. The uncommitted facilities are renewable within one year. Fair value of derivative financial instruments The fair values of derivative financial instruments are as follows: Assets Liabilities At Forward foreign currency contracts - cash flow hedge 1,296 523 - other 248 232 ----- ----- 1,544 755 === === At 31 December Forward foreign currency contracts - cash flow hedge 494 947 - other 78 668 ----- ----- 572 1,615 === === Assets and liabilities that are measured at fair value are disclosed by level of the following fair value measurement hierarchy: Level 1 Quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 Inputs other than quoted prices included within level 1 that are observable for the asset or liability either directly (that is, as prices) or indirectly (that is, derived from prices). Level 3 Inputs for the asset or liability that are not based on observable market data (that is, unobservable inputs). All of the group s assets and liabilities that are measured at fair value are classified as level 2 at (31 December : Level 2). 13
5. Segment information The chief operating decision maker has been identified as the Board. Historically the Board reviewed the group s financial results on a product segment basis with 3 identifiable operating segments: Collagen casings Distributed products Other products Following the sale in September of Devro Gmbh, the German distribution business, of which approximately 80% of sales related to third party distributed products (forming the bulk of the Distributed products segment), the group was left with two product segments Collagen casings and Other products. The Other products segment was deemed so small that essentially the group had one operating segment. The Board recognised that this may not fully reflect how they are now managing the business. As a consequence, the Board has reconsidered its operating segments and, in order to provide more meaningful information to users of the financial statements, there are now three operating segments based on geography. Geography was previously the secondary segmental split utilised by the Board to review the group s financial results in order to assess performance and allocate resource. The three geographical segments which have been identified to meet the requirements of IFRS 8 and which will now be reported are: Americas: which includes North America, Central America and Latin America Asia-Pacific: which includes Australia, New Zealand, Japan, China, Korea and the rest of South East Asia Europe: which includes Continental Europe, UK/ Ireland and Africa The Board assesses the performance of the operating segments based on a measure of adjusted earnings before interest and tax ( Adjusted EBIT ). This measurement basis excludes the effects of exceptional income and expenditure from the operating segments, of which there are none in the current or prior period. Finance income and expense, including that arising on pension assets and liabilities, is not included in the segment results that are reviewed by the Board. Information provided to the Board is consistent with that in the financial statements. Americas Asia - Pacific Europe Total continuing operations Discontinued operation * Total group,000 Revenue Sales to external customers 28,159 22,756 33,812 27,903 53,430 56,447 115,401 107,106 10,889 115,401 117,995 -- -- -- -- -- -- -- -- - -- --- Adjusted EBIT 2,840 2,580 3,653 2,378 16,441 16,243 22,934 21,201 110 22,934 21,311 -- -- -- - -- -- Corporate overheads (2,185) (1,717) - (2,185) (1,717) -- -- -- -- -- EBIT 20,749 19,484 110 20,749 19,594 Finance income 26 86-26 86 Finance expense (577) (468) (2) (577) (470) Net finance (expense)/inco me on pension (613) 547-613 547 -- -- -- -- -- Profit before taxation 19,585 19,649 108 19,585 19,757 ====== ====== ====== ====== ====== *There is no current period financial information relating to the discontinued operation. 14
6 Discontinued operation On 30 September, the group sold Devro GmbH, a wholly-owned subsidiary, to ViskoTeepak Holding Ab Ltd of Finland. The purchase price was based on adjusted net book value (excluding certain pension assets and liabilities). The estimated preliminary price of 1.9 million euros was paid on completion and after final adjustment in the first half of, this price was confirmed. As the group had reached conditional agreement for the sale on 16 June, the results for the business disposed of were presented in last year s interim financial statements as a discontinued operation, and the value of the assets and liabilities being disposed of at were presented as held for sale. There is no current year financial information relating to the discontinued operation and the prior year comparatives are set out below (a) Income statement for discontinued operation Revenue 10,889 Expenses (10,665) ---- Profit before taxation from discontinued operation 224 Taxation (73) Profit after taxation from discontinued operation 151 Expenses associated with the disposal of the discontinued (116) operation before taxation Taxation 31 Expenses associated with the disposal of the discontinued (85) operation after taxation Profit for the period from discontinued operation 66 15
6 Discontinued operation (continued) (b) Cash flows from discontinued operation Net cash used in operations (1,350) Net cash used in investing activities (4) Net cash from financing activities 915 Effect on cash flows (439) (c) Assets and liabilities classified as held for sale Assets Intangible assets 4 Property, plant and equipment 30 Inventories 2,149 Trade and other receivables 2,332 Cash 419 Total assets of the disposal group 4,934 Liabilities Trade and other payables 2,957 Current tax liabilities 356 Total liabilities of the disposal group 3,313 Net assets of the disposal group 1,621 16
7 Taxation The charge for taxation for the six months corresponds to a rate of tax of 19.7% on the profit on continuing operations for the period (: 20.5%), which reflects the anticipated effective rate for the year ending 31 December. The charge for taxation comprises a UK corporation tax credit of 30,000 (: charge of 135,000) and a foreign tax charge of 3,882,000 (: 3,893,000). During the period changes to the UK Corporation tax system were announced as part of the March UK Budget Statement. Legislation to reduce the main rate of corporation tax from 24% to 23% from 1 April 2013 was included in the Finance Act. A further reduction to the main rate is proposed to reduce the rate to 22% from 1 April 2014. These further changes had not been substantively enacted at the balance sheet date and, therefore, are not included in these financial statements. Had the change in rate to 22% been substantively enacted as of the balance sheet date, there would have been no significant impact on the accounts. 17
8 Earnings per share Profit attributable to equity holders - Continuing operations 15,733 15,621 - Discontinued operation - 66 15,733 15,687 Profit attributable to equity holders excluding net finance (expense)/income on pensions (continuing operations) 16,346 15,074 Earnings per share - continuing operations - Basic 9.5p 9.5p - Basic excluding net finance (expense)/income on pension 9.9p 9.2p - Diluted 9.4p 9.4p There are no earnings per share for discontinued operations. Basic earnings per share is calculated by dividing the profit for the period attributable to equity holders by 165,345,231 (: 164,129,526) shares, being the weighted average number of shares in issue throughout the period. Share options are only treated as dilutive in the calculation of diluted earnings per share if their exercise would result in the issue of shares at less than the average market price of the shares during the period. Shares arising from share options, the deferred bonus scheme or the performance share plan are only treated as dilutive where the effect is to reduce earnings per share. Diluted earnings per share are calculated by dividing the profit for the period attributable to equity holders by the average number of shares, including the effect of all dilutive potential shares, of 167,450,785 (: 166,674,120). 18
9 Dividends The final dividend of 5.5 pence per share in respect of the year 31 December was paid on 4 May, absorbing 9,061,000 of equity. The interim dividend of 2.65 pence per share, which will absorb an estimated 4,382,000 of equity, will be paid on 5 October to shareholders on the register at 31 August. This compares with the interim dividend of 2.5 pence per share, which absorbed 4,116,000 of equity. 10 Intangible assets Movements in intangible assets are summarised as follows: Opening net book value at 1 January 3,678 2,549 Less: classified as held for sale - (4) Exchange differences Additions (13) 438 34 1,012 Disposals - - Amortisation (500) (168) Closing net book value at 3,603 3,423 11 Property, plant and equipment Movements in property, plant and equipment are summarised as follows: Opening net book value at 1 January 180,215 157,024 Less: classified as held for sale - (38) Exchange differences Additions (4,397) 9,758 6,180 14,070 Disposals (159) (122) Depreciation (7,226) (6,745) --- --- Closing net book value at 178,191 170,369 ====== ====== Additions during the period were largely attributable to expenditure on capacity increases and productivity enhancements in each of the four manufacturing subsidiaries. 19
12 Capital commitments Capital expenditure contracted for but not provided in the financial statements: 000 31 December 000 Property, plant and equipment 13,780 11,956 21,180 Intangible assets - 21 8 - - 13,780 11,977 21,188 - - 13 Retirement benefit obligations The retirement benefit obligations disclosed as non-current liabilities in the balance sheet are as follows: 31 December Retirement benefit obligations 51,450-46,158-10,261 - The increase in the group s retirement benefit obligations at compared with 31 December primarily reflects the reduction in discount rates. A summary of the discount rates used in the principal countries is: 31 December Australia 2.60% 3.20% 4.60% United Kingdom 4.60% 4.70% 5.50% United States 3.84% 4.52% 5.36% 20
14 Equity securities issued Details of ordinary shares of 10 pence each issued during the six months are as follows: Shares Shares Shares vested under the Devro 2003 Performance Share Plan 520,000 ======== 1,036,557 ======== 378 === 761 === 15 Cash flows from operating activities Continuing operations Profit before tax 19,585 19,649 Adjustments for: Finance income (26) (86) Finance expense 577 468 Net finance (expense) /income on pension and post-retirement health plan assets and liabilities 613 (547) (Gain)/Loss on disposal of property, plant and equipment (43) 99 Loss on disposal of intangible assets - - Depreciation of property, plant and equipment 7,226 6,745 Amortisation of intangible assets 500 168 Release from capital grants reserve (40) (20) Expenses associated with the disposal of the discontinued operation - (116) Retirement benefit obligations (2,637) (2,424) Performance share plan 36 (342) Changes in working capital: Increase in inventories (3,929) (5,508) Increase in trade and other receivables (1,689) (1,510) Decrease in trade and other payables (1,071) (1,112) - - Cash generated from continuing operations 19,102 15,464 ===== ===== 21
16 Analysis of net debt 31 December Cash and cash equivalents 10,441 7,614 13,402 Bank overdrafts (4,931) (2,213) (4,321) --- --- --- 5,510 5,401 9,081 Borrowings: - Due within one year - - (33,102) - Due after more than one year (36,942) (28,103) - --- --- --- (31,432) (22,702) (24,021) ====== ====== ====== The increase in net debt reflects the significant level of capital expenditure during the period, together with the increase in working capital. 17 Related party transactions The group had no related party transactions other than key management compensation during the six months and. 22
Statement of directors responsibilities The directors confirm that these condensed interim consolidated financial statements have been prepared in accordance with International Accounting Standard ( IAS ) 34 as adopted by the European Union, that they give a true and fair view of the assets, liabilities, financial position and profit as a whole and that the interim management report includes a fair review of the information required by the Disclosure and Transparency Rules ( DTR ) 4.2.7 and 4.2.8, namely: an indication of important events that have occurred during the first six months and their impact on the condensed set of financial statements, and a description of the principal risks and uncertainties for the remaining six months of the financial year; and material related party transactions in the first six months of the financial year and any material changes in the related party transactions described in the last annual report. The directors of Devro plc are as listed in the company s Annual Report for the year 31 December, with the exception of the following changes: Jane Lodge was appointed on 1 March replacing Stuart Paterson as Audit Committee Chairman on 19 April. A list of the current directors is maintained on the company s website: www.devro.com. By order of the Board Peter Page Simon Webb Chief Executive Group Finance Director 31 July 31 July 23
Independent review report to Devro plc Introduction We have been engaged by the company to review the condensed interim consolidated financial information in the interim financial report for the six months, which comprises the interim consolidated income statement, the interim consolidated statement of comprehensive income, the interim consolidated balance sheet, the interim consolidated statement of changes in equity, the interim consolidated cash flow statement and related notes. We have read the other information contained in the interim financial report and considered whether it contains any apparent misstatements or material inconsistencies with the information in the consolidated interim financial information. Directors responsibilities The interim financial report is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing the interim financial report in accordance with the Disclosure and Transparency Rules of the United Kingdom s Financial Services Authority. As discussed in note 2, the annual financial statements of the group are prepared in accordance with IFRSs as adopted by the European Union. The condensed interim financial information included in this interim financial report has been prepared in accordance with International Accounting Standard 34, Interim Financial Reporting, as adopted by the European Union. Our responsibility Our responsibility is to express to the company a conclusion on the condensed interim financial information in the interim financial report based on our review. This report, including the conclusion, has been prepared for and only for the company for the purpose of the Disclosure and Transparency Rules of the Financial Services Authority and for no other purpose. We do not, in producing this report, accept or assume responsibility for any other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by our prior consent in writing. Scope of review We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410, "Review of interim financial information performed by the independent auditor of the entity", issued by the Auditing Practices Board for use in the United Kingdom. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK and Ireland) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. Conclusion Based on our review, nothing has come to our attention that causes us to believe that the condensed interim financial information in the interim financial report for the six months is not prepared, in all material respects, in accordance with International Accounting Standard 34 as adopted by the European Union and the Disclosure and Transparency Rules of the United Kingdom s Financial Services Authority. PricewaterhouseCoopers LLP Chartered Accountants Glasgow 31 July 24
Notes (a) (b) The maintenance and integrity of the Devro plc website is the responsibility of the directors; the work carried out by the auditors does not involve consideration of these matters and, accordingly, the auditors accept no responsibility for any changes that may have occurred to the interim financial report since it was initially presented on the website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions. 25